Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Finished Goods (2016 - 2021)

Historic Finished Goods for AtriCure (ATRC) over the last 13 years, with Q2 2021 value amounting to $21.6 million.

  • AtriCure's Finished Goods rose 2142.38% to $21.6 million in Q2 2021 from the same period last year, while for Jun 2021 it was $21.6 million, marking a year-over-year increase of 2142.38%. This contributed to the annual value of $20.6 million for FY2020, which is 2118.86% up from last year.
  • AtriCure's Finished Goods amounted to $21.6 million in Q2 2021, which was up 2142.38% from $22.3 million recorded in Q1 2021.
  • Over the past 5 years, AtriCure's Finished Goods peaked at $22.3 million during Q1 2021, and registered a low of $10.8 million during Q3 2018.
  • Over the past 5 years, AtriCure's median Finished Goods value was $14.1 million (recorded in 2017), while the average stood at $15.3 million.
  • As far as peak fluctuations go, AtriCure's Finished Goods plummeted by 2679.07% in 2018, and later soared by 5382.39% in 2020.
  • Over the past 5 years, AtriCure's Finished Goods (Quarter) stood at $13.4 million in 2017, then decreased by 9.29% to $12.2 million in 2018, then soared by 40.13% to $17.0 million in 2019, then increased by 21.19% to $20.6 million in 2020, then grew by 4.81% to $21.6 million in 2021.
  • Its Finished Goods stands at $21.6 million for Q2 2021, versus $22.3 million for Q1 2021 and $20.6 million for Q4 2020.